ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate
ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate Basic information
- Product Name:
- ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate
- Synonyms:
-
- 1-Ebpc
- 1H-Pyrrole-3-carboxylic acid, 2,5-dihydro-4-hydroxy-5-oxo-1-(phenylmethyl)-, ethyl ester
- Nsc 229530
- 1-Benzyl-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylic acid ethyl ester
- 1-Benzyl-4-bydroxy-5-oxo-3-pyrroline-3-carboxylic Acid Ethyl Ester
- 2,5-Dihydro-4-hydroxy-5-oxo-1-(phenylMethyl)-1H-pyrrole-3-carboxylic Acid Ethyl Ester
- CP-10668
- Aldose Reductase,inhibit,EBPC,Inhibitor
- CAS:
- 4450-98-0
- MF:
- C14H15NO4
- MW:
- 261.27
- Product Categories:
-
- Aromatics
- Heterocycles
- Inhibitors
- Intermediates & Fine Chemicals
- Pfizer Compounds
- Pharmaceuticals
- Mol File:
- 4450-98-0.mol
ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate Chemical Properties
- Melting point:
- 135-136 °C
- Boiling point:
- 479.8±45.0 °C(Predicted)
- Density
- 1.340±0.06 g/cm3(Predicted)
- storage temp.
- room temp
- solubility
- DMSO: ≥10mg/mL
- form
- white powder
- pka
- 4.50±1.00(Predicted)
- color
- white
ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate Usage And Synthesis
Description
The human aldose reductase AKR1B1 is considered the rate limiting enzyme of the polyol pathway responsible for the conversion of glucose into sorbitol. It also acts as a highly efficient PGF2α synthase in response to interleukin-
Uses
A highly specific aldose reductase inhibitor that has been shown to enhance HeLa cell sensitivity to chemotherapeutic drugs.
Definition
ChEBI: Ethyl 1-benzyl-3-hydroxy- 2-oxo[5H]pyrrole-4-carboxylate is a pyrroline and a carboxylic acid.
References
[1] B. L. MYLARI T W S T A Beyer. A Highly Specific Aldose Reductase Inhibitor, Ethyl 1-Benzyl-3-hydroxy- 2(5H)-oxopyrrole-4-carboxylate, and Its Congeners.[J]. ChemInform, 1991, 90 1. DOI: 10.1002/chin.199127155
[2] EUN KYOUNG LEE Paul S William T Regenold. Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases.[J]. Anti-Cancer Drugs, 2002, 13 8: 859-868. DOI: 10.1097/00001813-200209000-00012
[3] EVA BRESSON. The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions.[J]. Frontiers in Pharmacology, 2012, 3: 98. DOI: 10.3389/fphar.2012.00098
ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylateSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 13526569071
- sales@leadmedpharm.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 888-539-0666
- info@emmx.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate(4450-98-0)Related Product Information
- 1-BENZYL-1,5-DIHYDRO-PYRROL-2-ONE
- Ethyl 3-(benzylamino)propanoate
- 1-Benzyl-2,5-dihydro-1H-pyrrole
- 1-(4-Methoxybenzyl)-3-hydroxy-4-ethoxycarbonyl-5-(3-pyridyl)-3-pyrrolin-2-one
- ETHYL 3-(N-BENZYL-N-METHYLAMINO)PROPANOATE
- 1-BENZYL-2,5-DIHYDRO-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER
- ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate